St. Jude Medical receives FDA approval for wireless spinal cord stimulation: 5 things to know

Megan Wood  -   Print  |

St. Jude's Invisible Trial System is the first SCS trial system to use Bluetooth and Apple technology. The wireless system is designed to limit distractions caused by bulky cables and complex controllers, so chronic pain patients can more accurately assess the impact of the therapy.

Here are five things to know:


1. The Invisible Trial System introduces an iPod touch for a controller and iPad for physician evaluation, creating a wireless therapy that is intended to improve patient experience.


2.  The Bluetooth technology in communication with a small external pulse generator allows the system to be worn discreetly under clothes, making it feel "invisible."


3. The iPad mini allows physicians to view, print and email EPG data in PDF format and the iPod touch provides patients with a simple platform to adjust their therapy.


4. St. Jude Medical Group President, Eric S Fain, MD, said this new therapy is patient-friendly and will "shorten the learning curve," so patients can more accurately assess the potential pain relief.


5. St. Jude Medical works to transform treatment of the most expensive epidemic diseases like chronic pain, which affects approximately 1.5 billion people worldwide.


More articles on devices:
J&J Orthopedics sales drop 5.6% in Q2: 5 key notes
5 observations on Smith & Nephew's stock rating downgrade
K2M Director sells 576k shares: 5 notes

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers